SignalGeopolitics
FDA scientists opposed Trump administration’s move to ease peptide access
FDA scientists' opposition signals regulatory conflict over Trump's peptide access policy.
Context
What happened: FDA scientific staff largely opposed a plan to ease access to unproven injectable peptides favored by HHS secretary Robert F Kennedy Jr, and had limited input in drafting the policy posted online Wednesday.
Why it matters: The policy covers peptides promoted in the wellness industry for building muscle, healing injuries and boosting energy, and drew fierce pushback from agency scientists.
What changed
FDA scientific staff largely opposed a plan to ease access to unproven injectable peptides favored by HHS secretary Robert F Kennedy Jr, and had limited input in drafting the policy posted online Wednesday.
Why it matters
The policy covers peptides promoted in the wellness industry for building muscle, healing injuries and boosting energy, and drew fierce pushback from agency scientists.